settled-reach/wiki/corporations/prometheus-labs.md

title, description, slug, category, status, created, updated, scope, faction_type, headquarters, tags, decision_refs, cross_refs

title	description	slug	category	status	created	updated	scope	faction_type	headquarters	tags	decision_refs	cross_refs
Prometheus Labs	Creator and sustained provider of the longevity and implant technology that makes Perpetual-class life possible — the company that decided who gets to live for centuries	prometheus-labs	corporation	canonical	2026-03-14	2026-03-14	reach-wide	economic	Prometheus (GJ 702B)

Prometheus Labs

Type: Corporation — Biotechnology / Longevity Infrastructure Status: Canonical Scope: Reach-wide Headquarters: Prometheus (GJ 702B) — dead-end system, 1 aperture, adjacent to Ran System Holdings: Prometheus (GJ 702B) Classification: Syndic-adjacent; operates outside standard commercial taxonomy

---

Overview

Prometheus Labs created the implant and longevity hardware that makes Perpetual-class existence possible. Every human being in the Reach who has lived for more than a century — every founding Assembly member still casting votes, every Wave 1 industrialist still managing their centuries-old enterprise, every researcher who has been studying the horizon stations since before most current citizens were born — is alive because of Prometheus Labs technology and continues to be alive because of ongoing Prometheus Labs maintenance.

This is not a product you buy once. Extended longevity requires sustained hardware — implants that interact with biological systems over decades, maintenance protocols that update as bodies age in ways they were never designed to age, calibration services that address the accumulated drift of biological systems operating outside their evolved parameters. A Perpetual-class individual who stops their Prometheus maintenance schedule does not stop being Perpetual-class immediately. The deterioration is gradual. But it is not reversible once it reaches certain thresholds, and Prometheus Labs has spent three centuries ensuring that the maintenance infrastructure required to avoid those thresholds is only available through Prometheus Labs.

The company chose its name deliberately. They gave extended life. The classical reference was their own.

---

Origin

Prometheus Labs emerged from the early settlement period's medical research environment, when the Veil Institute's founders — recognizing they were embarked on a multi-generational research program — created the institutional demand for human lifespans capable of sustaining that program across centuries. The first longevity protocols were not designed for commerce. They were designed to keep researchers alive long enough to finish work that could not be finished in a single human lifetime.

The technology's commercial potential was recognized quickly. The founding generation of what became Prometheus Labs was close to the Institute's early administration — the relationship between the two institutions dates to their origins, which is one reason it is so difficult to characterize from outside. The Lab's first clients were the Institute's own researchers. Its second clients were the Assembly's founding delegates, who faced a governance problem: institutions built on elected terms struggle to maintain continuity when the institutional knowledge required to govern effectively takes decades to accumulate. Extended lifespans did not solve this problem. They transformed it.

The company that emerged from these origins is now the sole provider of Perpetual-class longevity maintenance across the Reach. This position was not achieved through monopoly enforcement. It was achieved by being first, by accumulating three centuries of proprietary knowledge about how extended human biology actually behaves, and by making the alternatives — any alternatives — cost-prohibitive for anyone who has already committed to the longevity track.

---

Operations

Initial treatment: The Prometheus longevity protocol requires a multi-stage initial treatment sequence. The protocols are not fully standardized — they are tailored to individual biological profiles in ways that create dependencies specific to each patient's treatment history. This is presented as medical necessity. It also means that a client who has undergone initial Prometheus treatment cannot transfer their maintenance relationship to a different provider without significant risk. There is, in practice, no different provider capable of managing a Prometheus treatment history.

Ongoing maintenance: Perpetual-class clients require periodic maintenance visits. The schedule varies by client profile and longevity generation — earlier protocols require more frequent maintenance; more recent treatments are more stable but still require monitoring. Prometheus Labs' maintenance network is not as geographically distributed as the Gate Corporation's or MVG's operational footprints. Prometheus has treatment facilities at major hub systems, but clients in peripheral systems travel to receive maintenance, or arrange for Prometheus field teams to travel to them. The cost of the latter is substantial.

Cognitive and neural augmentation: Beyond longevity, Prometheus Labs produces medical implants and neural enhancement hardware that does not require the longevity protocol. These products are commercially distributed through standard Syndic-adjacent channels and are subject to Lattice Commission regulation. The longevity protocols themselves occupy a different regulatory category — the Commission regulates the standard neural lattice; Prometheus longevity hardware interfaces with the lattice but is governed under a separate framework negotiated directly with the Assembly. The precise terms of that framework are not public.

Research: Prometheus Labs maintains active research operations. What they are researching is not published in any complete form. Medical research, they say. The practical implication of three centuries of continuous research on aging, longevity, and the biology of extended-lifespan humans is that Prometheus knows more about how Perpetual-class bodies actually work than any other institution — more than the Commission, more than the Assembly's medical offices, more than the clients themselves.

---

System Holdings

Prometheus (GJ 702B) — dead-end system, single aperture, adjacent to Ran. One way in, one way out.

The choice of a dead-end system is significant. A single aperture is the most defensible gate topology in the network: control the one gate, control all access. Prometheus Labs has maintained this system for three centuries, and the gate has never been forced. The Reach has no mechanism to force a gate — gates cannot be deactivated; access to the space around a gate can be controlled; the one gate at Prometheus has been controlled by Prometheus security personnel continuously since the corporation's founding.

The adjacency to Ran is also deliberate. Ran feeds the Reach. Prometheus feeds Ran's access to longevity services. The two systems are economically intertwined in ways that neither discusses as leverage, but the structure is visible.

Prometheus system itself has the character of a place designed to discourage casual visits. The gate transit experience is smooth — Prometheus maintenance facilities are well-appointed for clients who have been maintaining relationships for decades. The security apparatus around the research facilities and administrative core is not visible to clients but is extensive. Prometheus employees do not discuss what happens outside the client-facing areas of the system.

---

Political Relationships

The Veil Institute: The founding relationship between the two institutions is the most significant and least documented connection in either organization's history. The Institute's researchers are Perpetual-class. They have been so since before the Reach's independence, and they have been studying horizon stations for five centuries because Prometheus Labs technology makes five centuries of continuous research possible. Whether Prometheus Labs provides preferential longevity terms to Institute researchers — and what the Institute provides in return — is not addressed in any accessible document from either organization.

The practical consequence is that the people who know the most about the Reach's alien infrastructure, and the people who decide how long the most powerful individuals in the Reach continue to live, have a relationship dating to the founding period that has never been formally characterized.

The Concord Assembly: The Assembly's founding delegates are still alive. Their extended lifespans — and the longevity maintenance schedules that sustain those lifespans — are managed by Prometheus Labs. This is not described as a dependency in Assembly governance frameworks. It is not described as anything in Assembly governance frameworks. The founding delegates who drafted those frameworks were already Prometheus clients when they wrote them, and Prometheus's position was too foundational to the project of the Reach itself to characterize as a commercial relationship.

The Assembly has never passed meaningful legislation constraining Prometheus Labs' pricing, access protocols, or client selection criteria. The Commission does not regulate the longevity protocol under its standard framework. These absences are not accidents. They reflect the position of a company that was embedded in the Reach's founding institutions before those institutions were finished being founded.

The Lattice Commission: The Commission regulates Prometheus's standard medical implant and neural augmentation product lines. It does not regulate the longevity protocols. The distinction is maintained by a regulatory carve-out that dates to the Commission's founding and has never been successfully challenged. The Commission's position is that the longevity protocol is a specialized medical procedure outside the Commission's technical jurisdiction. Prometheus's position is the same. Whether this is the correct regulatory framework or whether it reflects the capture of regulatory design by the regulated entity is a question that Commission researchers raise in internal documents and do not raise publicly.

The Syndics: Prometheus Labs is Syndic-adjacent in commercial classification but does not operate within standard Syndic network structures. It does not compete for freight contracts or infrastructure deals. Its product is not distributed through Syndic logistics except for the standard medical lines. Prometheus occupies a separate tier — not because it is outside commerce, but because its commercial relationships are with individuals who live for centuries, and the revenue model of multi-century client relationships does not fit standard Syndic commercial patterns.

---

What They Don't Talk About

Prometheus Labs does not discuss client selection criteria. Extended longevity technology is not universally available. The protocols are expensive; the maintenance is ongoing; the initial treatment requires acceptance into a Prometheus client program. How those acceptance decisions are made — what criteria Prometheus applies, whether those criteria have ever been political, whether access has ever been granted or denied on grounds other than medical suitability and financial qualification — is not addressed in any public documentation.

The practical consequence of three centuries of selective access is the Reach's class structure. Perpetual-class individuals are those who received access. Everyone else lives on biological time. The gates, the vehicles, the neural lattice, the Meridian — all of these technologies are broadly accessible. Longevity is not. Prometheus Labs made that choice, continuously, for three centuries.

The second silence concerns what Prometheus knows. Three hundred years of research on extended human lifespans has produced proprietary knowledge that no other institution possesses. What the biology of multi-century humans actually reveals — about cognition, about accumulated experience, about whatever happens to human decision-making when compressed evolutionary pressures operate over timescales they were never designed for — is Prometheus research data. It has not been published. The researchers who hold it are Perpetual-class. They will not publish it in any foreseeable timeframe, because for them, there is no foreseeable timeframe.

---

Gameplay Relevance

Prometheus Labs is not present in the v0.1 slice. Its relevance is structural.

The economic pressure that makes smuggling rational in Van Maanen's Star — the gap between what workers earn and what lattice components cost — is downstream of a class structure that Prometheus Labs created and sustains. Workers who cannot afford enhanced neural lattice access cannot afford it in part because the Commission's regulatory costs are set by institutions whose Perpetual-class leadership has never had to make the same economic calculations. Prometheus Labs is not responsible for that lattice pricing. But Prometheus Labs made the Perpetual class, and the Perpetual class made the regulatory framework, and the regulatory framework made the smuggling market.

For investigation, Prometheus Labs is an access problem of the highest order. The corporation has the most defended system in the Reach's gate topology, the most legally insulated regulatory status, and client relationships with the most powerful individuals in every institution the player might approach for assistance. A player who finds leverage on Prometheus Labs has found leverage on everything else simultaneously. That is why no one has managed it in three hundred years.

---

Cross-References:

• Veil Institute — Founding relationship; reciprocal dependencies undisclosed
• Concord Assembly — Founding delegates as clients; regulatory capture
• Lattice Commission — Partial regulation; longevity protocol carve-out
• Syndics — Commercial adjacency; operates outside standard Syndic patterns
• Neural Lattice — Adjacent technology; shared but distinct regulatory domain
• Clone Transfer — Interacts with longevity protocols in complex ways

---

Status: Canonical Created: 2026-03-14 Updated: 2026-03-14